DISRUPTING THE NORDIC INVESTMENT AND HEALTHCARE SPACE
The LSX Nordic Congress brings together the best in Nordic Biotech, MedTech and HealthTech with an unparalleled pan-European investor network
London, UK, May 8, 2019 - LSX Ltd is pleased to announce The 2nd annual Nordic Congress, a unique senior executive conference and partnering event bringing together pan-European investment with Nordic Biotech, Medtech and Health-tech innovators. Over 30 companies are confirmed to present alongside a high-calibre speaker faculty and Europe's leading investors.
The Nordic region has long produced world-leading science and innovation and, now in its second year, the LSX Nordic Congress will be all about showcasing this innovation, both of the region's industry leaders but also through start-ups and technology innovators driving the future of healthcare.
Russell Gardiner, Marketing Manager, LSX, said: "The 2019 LSX Nordic Congress is looking to be a gamechanger for life sciences investment in the region. We’re buoyed by the interest from Nordic life science innovators thus far, and we’re excited to be delivering a world-class event for them to meet investment".
Limited tickets for the LSX Nordic Congress are still available at www.lsxleaders.com/lsx-nordic-congress-register.
You can also check out the full brochure here:
The 2nd LSX Nordic Congress is organised by LSX, an influential community of senior life science decision makers. Through impactful events, powerful thought leadership content and unique networking opportunities, LSX exists to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. For more information please visit www.lsxleaders.com or www.lsxleaders.com/nordic